- Home
- PRTA vs IHRT Comparison
PRTA vs IHRT Comparison
Compare PRTA & IHRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRTA | IHRT |
|---|---|---|
| Founded | 2012 | 1974 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Broadcasting |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 595.9M | 711.8M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | PRTA | IHRT |
|---|---|---|
| Price | $9.27 | $4.37 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $18.86 | $4.50 |
| AVG Volume (30 Days) | 617.1K | ★ 1.1M |
| Earning Date | 11-06-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $11,786,000.00 | ★ $3,856,033,000.00 |
| Revenue This Year | N/A | $1.96 |
| Revenue Next Year | $819.08 | $5.62 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1.39 |
| 52 Week Low | $4.32 | $0.95 |
| 52 Week High | $17.66 | $5.44 |
Technical Indicators
Market Signals| Indicator | PRTA | IHRT |
|---|---|---|
| Relative Strength Index (RSI) | 36.68 | 55.73 |
| Support Level | $9.69 | $4.26 |
| Resistance Level | $10.50 | $5.44 |
| Average True Range (ATR) | 0.57 | 0.36 |
| MACD | -0.16 | 0.00 |
| Stochastic Oscillator | 6.50 | 41.26 |
Price Performance
Historical ComparisonAbout PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About IHRT iHeartMedia Inc.
iHeartMedia Inc is a United States-based audio media company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.